These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20646558)

  • 1. [The effects of different hydration strategies before endovascular treatments to the renal function of the arteriosclerosis obliterans patients].
    Zhu YT; Xiong J; Guo W; Liu XP; Yin T; Jia X; Ma XH; DU X
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(17):1155-8. PubMed ID: 20646558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
    Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
    Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Maioli M; Toso A; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Bellandi F
    J Am Coll Cardiol; 2008 Aug; 52(8):599-604. PubMed ID: 18702961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium bicarbonate versus normal saline for protection against contrast nephropathy.
    Budhiraja P; Chen Z; Popovtzer M
    Ren Fail; 2009; 31(2):118-23. PubMed ID: 19212908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
    Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O
    Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial).
    Lee SW; Kim WJ; Kim YH; Park SW; Park DW; Yun SC; Lee JY; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Suh J; Cho YH; Lee NH; Cheong SS; Yoo SY; Lee BK; Lee SG; Hyon MS; Shin WY; Lee SW; Jang JS; Park SJ
    Am J Cardiol; 2011 May; 107(10):1447-52. PubMed ID: 21420063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency.
    Hans SS; Hans BA; Dhillon R; Dmuchowski C; Glover J
    Am Surg; 1998 May; 64(5):432-6. PubMed ID: 9585778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention.
    Seyon RA; Jensen LA; Ferguson IA; Williams RG
    Heart Lung; 2007; 36(3):195-204. PubMed ID: 17509426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
    Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H
    Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.
    Masuda M; Yamada T; Mine T; Morita T; Tamaki S; Tsukamoto Y; Okuda K; Iwasaki Y; Hori M; Fukunami M
    Am J Cardiol; 2007 Sep; 100(5):781-6. PubMed ID: 17719320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention.
    Shemirani H; Pourrmoghaddas M
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):280-5. PubMed ID: 22382219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
    Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
    Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T
    J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.
    Ramesh N; Pillai RK; Abraham T; Padmaja NP; Hameed S; Vijayaraghavan G
    J Assoc Physicians India; 2006 Jun; 54():449-52. PubMed ID: 16909692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 20-Hour preprocedural hydration is not superior to 5-hour preprocedural hydration in the prevention of contrast-induced increases in serum creatinine and cystatin C.
    Torigoe K; Tamura A; Watanabe T; Kadota J
    Int J Cardiol; 2013 Sep; 167(5):2200-3. PubMed ID: 22717305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy.
    Baskurt M; Okcun B; Abaci O; Dogan GM; Kilickesmez K; Ozkan AA; Ersanli M; Gurmen T
    Eur J Clin Invest; 2009 Sep; 39(9):793-9. PubMed ID: 19500141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of n-acetylcysteine in preventing contrast-induced nephropathy in type 2 diabetic patients without nephropathy.
    Sar F; Saler T; Ecebay A; Saglam ZA; Ozturk S; Kazancioglu R
    J Nephrol; 2010; 23(4):478-82. PubMed ID: 20383874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
    Toso A; Maioli M; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Manzone C; Amato M; Bellandi F
    Am J Cardiol; 2010 Feb; 105(3):288-92. PubMed ID: 20102936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
    Dussol B; Morange S; Loundoun A; Auquier P; Berland Y
    Nephrol Dial Transplant; 2006 Aug; 21(8):2120-6. PubMed ID: 16611682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-induced nephrotoxicity in renal allograft recipients.
    Ahuja TS; Niaz N; Agraharkar M
    Clin Nephrol; 2000 Jul; 54(1):11-4. PubMed ID: 10939751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.